Research / CRNC / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-22-004129 General Corporate
Debt relative to revenue 75th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.debt_to_revenue
287.08% · OPTIONAL · VALID
Capex intensity 63th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.67% · OPTIONAL · VALID
Operating cash generation 13th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
5.45% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-0.57% · CORE · NOT_ENOUGH_HISTORY
Gross margin 88th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_margin
74.34% · CORE · VALID
Operating margin 100th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.operating_margin
24.29% · CORE · VALID
R&D intensity 38th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
27.31% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
6.19% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Sep 30, 2021 0/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 70.08%
Current 287.08%
Delta 217.00% Capex Intensity Increased
Previous 3.11%
Current 4.67%
Delta 1.56% Cash Generation Decreased
Previous 19.21%
Current 5.45%
Delta -13.76% Growth Decreased
Previous 17.45%
Current -0.57%
Delta -18.02% Margin Increased
Previous 73.89%
Current 74.34%
Delta 0.45% Profitability Increased
Previous 15.65%
Current 24.29%
Delta 8.64% R And D Intensity Decreased
Previous 28.95%
Current 27.31%
Delta -1.63% Sbc Intensity Decreased
Previous 15.64%
Current 6.19%
Delta -9.45% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.